Vés al contingut

A multi-center, randomized, double-blind, placebo controlled, parallel-group PhaseIIIb study evaluating the effect of inclisiran on atherosclerotic plaque progressionassessed by coronary computed tomography angiography (CCTA) in participantswith a diagnosis of non-obstructive coronary artery disease without previouscardiovascular events

Obert
  • Codi protocol: CKJX839D12303
  • Codi EudraCT: 2021-004601-47
  • Grup de recerca: Malalties Cardiovasculars
  • Servei: Cardiologia
  • Investigador/a principal:  Rodríguez Palomares, Jose Fernando
  • Malaltia: Malalties del sistema circulatori
  • Fase: Fase III
  • Estat: Reclutant voluntaris